Posts Tagged ‘medical devices’

Congratulations to Withings!

January 22nd, 2016
Posted by

Congratulations to our client, Withings, for being honored with the 2016 CES Innovation Awards in two categories, as well as being given the ‘Best of CES’ Awards from many major publications. Withings hit the press jackpot with their two latest innovations:
Read the rest of this entry »

Tags: , , , , , ,
Posted in Diagnostics, Digital health, Our News | Comments Off on Congratulations to Withings!

Dealing with the Growing Power of “Medical Googlers”

November 7th, 2012
Posted by

The increased use of the internet by healthcare consumers has led to at least two types of medical conversations ironically illustrated by two different online features sharing a name: the “DocTalk” here, in which Arizona kidney specialists share treatment information on smartphones, and another “DocTalk,” where Ontario physician Stuart Foxman discusses such communications issues as the risks of physician’s giving too much information, and the growing irritation among physicians with patients who research conditions and treatments online.
Like it or not, these two “doc talks” are merging. While physicians and other providers are busily keeping up with changing practice parameters, medical literature and patient management (increasingly by computer, smartphone or tablet), patients are trying to keep up, too. WebMD receives more than 40 million hits a month, and anywhere from half to 80% of all Americans have used the internet to research a medical condition or symptoms. Even larger medical providers like Kaiser Permanente encourage the use of websites for gathering medical information. In addition, consumers increasingly have the ability to research and share opinions on their providers through sites like  Interestingly, the ability of consumers to rate and offer opinions on providers is not growing quite as quickly as other industries, due to reasons we’ll cover in a future post.
  Read the rest of this entry »

Tags: , , , , ,
Posted in Our Views | 1 Comment »

The Physician’s New World of Consumer-Driven Healthcare: A View from Eric Topol

September 25th, 2012
Posted by

We’ve had a lot of discussions about the waves of changes happening in healthcare, thanks to smartphone- and internet-fueled consumer power. In a recent Popper and Company post, Caroline Popper discussed how consumers’ access to information, expectations from the medical profession, focus on wellness (instead of disease) and determination of value are changing the industry.
Dr. Eric Topol, author of The Creative Destruction of Medicine, presented another face of this consumer-driven change; the effects on doctors. In this Medscape video presentation, Dr. Topol suggests that doctors, no longer the sole holder of personal health information, will need to change how they approach their practices as well as their patients.
Consumers are getting health information from many sources. For example, companies like Walgreens are increasing the information content of their consumer interactions. By educating its customers on the data generated by the devices Walgreens sells, patients have more knowledge of their own condition – and a knowledge base that does not start with the physician. Thus, the patient enters the doctor’s office with a more thorough basis of information and more challenging questions. This information base may make physicians uncomfortable, just as direct-to-consumer ads from the pharmaceutical industry have discomforted many. But, as Dr. Topol points out, physicians will continue to have an important role; it’s just going to be a different one.’
  Read the rest of this entry »

Tags: , , , , ,
Posted in Our Views | Comments Off on The Physician’s New World of Consumer-Driven Healthcare: A View from Eric Topol

Consumers to Battle the Healthcare Gods

July 25th, 2012
Posted by

There’s a joke that’s often shared by medical students: “What’s the difference between God and a doctor? God doesn’t think he’s a doctor.” Regardless of your spiritual orientation, the line illustrates the lofty perch (and decision-making power) occupied by physicians in today’s healthcare settings. But, as we at Popper and Co. have discussed, a new wave of consumer power may eventually topple this perch.
A recent story in the Wall Street Journal by author Doc Searls, “The Customer as a God,” focused on the growing power of customers using electronic devices for daily communication, shopping and other activities. Most current product development, the article points out, focuses on improving the supply of products to the customer, not involving the customer in making those products. This however, is changing. The story projected a future in which people use their devices to pick out clothes, replace parts for appliances, and shop for products—all unencumbered by invasive marketing tracking methods, corporate service plans, and other systems that, as Searls says, “tend to herd customers as if they were cattle.”
  Read the rest of this entry »

Tags: , , , , , , ,
Posted in Our Views | Comments Off on Consumers to Battle the Healthcare Gods

Some Thoughts from 2012 AusMedTech Conference

May 24th, 2012
Posted by

While securing financing is an important milestone for developing new healthcare technologies, developers need to look beyond this first step and find ways to determine and demonstrate the value of their innovations. And there’s no better place to discuss this crucial issue than in Australia.
Home to 600 medical device companies, Australia ranks as the fourth-largest market in the Asia-Pacific region. I wrote this post last week from the 2012 AusMedTech (Australia Medical Technology) national conference in Sydney after sharing some strategic insights with device executives.
As the device industry continues to grow rapidly, it will be important for technology developers to demonstrate how their products add value to healthcare. No matter where they are located in the world, developers need to:

Tags: , , , , , ,
Posted in Events | Comments Off on Some Thoughts from 2012 AusMedTech Conference

Where is the Device Industry’s Seat at the “Network of Experts” Table?

December 8th, 2011
Posted by

Recent draft polices from the FDA’s Center for Devices and Radiological Health (CDRH) have created concern by industry members that they have been left out of the “network of experts,” a program to supplement the FDA’s existing expertise and to expedite the review process. Despite the fact that the FDA has more than 800 scientists, engineers and clinicians, the agency believes that it is impractical to expect CDRH staff to keep current with so many new and complex technologies surfacing.
The network of experts is designed to be a resource for CDRH, particularly to address questions on emerging and unfamiliar technologies. The outside organizations that are being considered by CDRH for inclusion in the network “…will include professional scientific and medical organizations and academic institutions.”  Even though we have not yet heard what organizations the FDA will use in a pilot program to assess their new process, a number of organizations are interested in participating in the program. Industry also would like a seat at the table.

  Read the rest of this entry »

Tags: , , , , , ,
Posted in Our Views | Comments Off on Where is the Device Industry’s Seat at the “Network of Experts” Table?

What You Need to Know About AdvaMed 2011

September 19th, 2011
Posted by

An Interview with AdvaMed Conference Producer Ray Briscuso
In preparation for AdvaMed 2011: The MedTech Conference, we had a unique opportunity to interview Ray Briscuso, President and CEO at Life Sciences Conference Group, LLC. Each year, Briscuso works with the Advanced Medical Technology Association (AdvaMed) to produce one of the most important meetings focused on medical devices and diagnostics, and which brings together more than 1,500 key MedTech executives from companies in every sector of the industry. It is the premier conference, exhibition and partnering event for medical device, diagnostic and health information companies. In the past, internationally respected voices, such as former Presidents George Bush (Sr.) and Bill Clinton, have been featured as plenary speakers.
I am eagerly anticipating September 26-28 when AdvaMed 2011 will be held in Washington, DC. Following are some insights and highlights from our discussion with Ray about how to get the most out of this year’s event: Read the rest of this entry »

Tags: , , , , , ,
Posted in Interviews | Comments Off on What You Need to Know About AdvaMed 2011

Expert’s View: Trends in Trans-Atlantic Life Science Technology

June 7th, 2011
Posted by

In my May 17 blog post, I introduced Dr. Andreas Muehler as one of Popper and Co.’s new strategic advisors. Dr. Muehler brings broad perspectives and business insights, owing in part to his close relationships with established industry leaders in the joint development and commercialization of medical products worldwide. Building upon our last discussion, where I was caught by his enthusiasm as we talked about his past role as CEO for a struggling medical device firm and his experiences positioning products in the global marketplace, I recently talked with Dr. Muehler again to further explore his impressions on the differences between the E.U. and U.S. markets for new life science technologies.
CP:  You’ve served within or supported the pharmaceutical and medical device industries in both Europe and the U.S. What do you see as some of the differences?

  Read the rest of this entry »

Tags: , , , ,
Posted in Interviews | Comments Off on Expert’s View: Trends in Trans-Atlantic Life Science Technology

TRI-CON – Diagnostics, Drug Discovery & Biologics: Oh My!

February 21st, 2011
Posted by

Sometimes, between the hotel room, the lectures, the networking, the power lunches and the data consumption at a conference, you’re on the plane home before you have time to reflect upon why you attended in the first place. I’m excited to be heading to the 18th International Molecular Medicine Tri-Conference in San Francisco this week—and I’m setting out my reasons for going this year beforehand.
I always look forward to this conference because of its balanced range of life science topics, including those with technical, scientific, business, strategy, regulatory and reimbursement slants. Within this balanced range of topics, the Tri-Con uses a channel structure to help attendees “tune in” where they can get the biggest bang for their buck. I’m excited to learn more about the following specifics within each channel: Read the rest of this entry »

Tags: , , , , , , , , , , ,
Posted in Our News | Comments Off on TRI-CON – Diagnostics, Drug Discovery & Biologics: Oh My!

The Phenomena Otherwise Known as DTC Genetic Tests

February 14th, 2011
Posted by

“I looked in the Yellow Pages. ‘Furniture Movers’ we’ve got; ‘Strange Phenomenon’, there’s no listing.” – Diane in Poltergeist
I had to laugh at one of last week’s headlines on the Daily Scan from Genome Web. It was titled, “They’re Baaaaaack!” Before reading the article, I imagined it had something to do with the Poltergeist series of movies where chaos and unexplained phenomena occur – objects careening through the air along with visitations from old and terrifying ghosts.   But when I read the article, it had to do with the revisiting of the direct-to-consumer genetic (DTC) tests rather than some type of paranormal activity.  Not exactly a poltergeist but nevertheless a phenomenom that 1) won’t go away, 2) is somewhat chaotic, and 3) is worth following.
From March 8-9, 2011, the Molecular and Clinical Genetics Panel of the FDA’s Medical Devices Advisory Committee will host a public meeting.  The group will take comments and make recommendations on DTC tests.  Several issues are on the agenda with the focus on the risk and benefits of such tests and the potential availability to consumers without a physician’s prescription.
  Read the rest of this entry »

Tags: , , , , ,
Posted in Our Views | Comments Off on The Phenomena Otherwise Known as DTC Genetic Tests

« Older Entries